Abstract: The present invention relates to a method for selecting pharmacological compounds for selective inhibition of cancer cells comprising identifying a compound, determining the reduction potential (ER) of the compound, and selecting the compound which has a reduction potential from ?1.1 to ?0.8 volts. The invention also relates to a pharmacological compound comprising at least one cyanine dye or merocyanine dye, wherein the dye has at least one cationic substituent, wherein the dye has a reduction potential of from—1.1 to 0.8 volts, and wherein the pharmacological compound demonstrates selective inhibition of cancer cells.

Abstract: An electroluminescent device comprises a layer containing a naphthalene compound represented by Formula (1), wherein: each R1 and R2 represents an independently selected substituent provided that adjacent substituents may join to form a ring; p and w independently are 0-3; the amine nitrogens on the naphthalene nucleus are located on separate rings; m and n independently are 0, 1 or 2; each Arb represents an independently selected aromatic group; and each Ara represents an independently selected phenylene, biphenylene or naphthalene group; provided that at least one R1 or R2 substituent of the naphthalene compound represented by Formula (1) is a sterically bulky substituent.

Abstract: Disclosed is an electroluminescent device comprising a cathode, an anode, and located therebetween a light emitting layer (LEL) containing (1) a host material that comprises a N,N,N?,N?-tetra-aromatic benzidine group substituted in at least one position ortho to the biphenyl linkage between the phenyl groups of the benzidine nucleus and (2) a phosphorescent light emitting material, wherein the triplet state energy of the benzidine nucleus is higher than the triplet state energy of the phosphorescent emitting material.